ES2523401T3 - Intermedios de un nuevo procedimiento para la preparación de derivados de 5-benciliden-2-alquilimino-3- feniltiazolidin-4-ona - Google Patents

Intermedios de un nuevo procedimiento para la preparación de derivados de 5-benciliden-2-alquilimino-3- feniltiazolidin-4-ona Download PDF

Info

Publication number
ES2523401T3
ES2523401T3 ES12000613.5T ES12000613T ES2523401T3 ES 2523401 T3 ES2523401 T3 ES 2523401T3 ES 12000613 T ES12000613 T ES 12000613T ES 2523401 T3 ES2523401 T3 ES 2523401T3
Authority
ES
Spain
Prior art keywords
hydroxy
thiazolidin
benc
iliden
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12000613.5T
Other languages
English (en)
Spanish (es)
Inventor
Stefan Abele
Martin Bolli
Gunther Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actelion Pharmaceuticals Ltd
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES2523401T3 publication Critical patent/ES2523401T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES12000613.5T 2006-11-23 2007-11-22 Intermedios de un nuevo procedimiento para la preparación de derivados de 5-benciliden-2-alquilimino-3- feniltiazolidin-4-ona Active ES2523401T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2006054409 2006-11-23
WOPCT/IB2006/054409 2006-11-23

Publications (1)

Publication Number Publication Date
ES2523401T3 true ES2523401T3 (es) 2014-11-25

Family

ID=39316391

Family Applications (2)

Application Number Title Priority Date Filing Date
ES12000613.5T Active ES2523401T3 (es) 2006-11-23 2007-11-22 Intermedios de un nuevo procedimiento para la preparación de derivados de 5-benciliden-2-alquilimino-3- feniltiazolidin-4-ona
ES07849225T Active ES2410793T3 (es) 2006-11-23 2007-11-22 Nuevo procedimiento para la preparación de derivados de 2-imino-tiazolidin-4-ona

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES07849225T Active ES2410793T3 (es) 2006-11-23 2007-11-22 Nuevo procedimiento para la preparación de derivados de 2-imino-tiazolidin-4-ona

Country Status (13)

Country Link
US (1) US8263780B2 (OSRAM)
EP (2) EP2094676B1 (OSRAM)
JP (1) JP4669564B2 (OSRAM)
KR (1) KR101255879B1 (OSRAM)
CN (2) CN103087004A (OSRAM)
AU (1) AU2007323042B2 (OSRAM)
CA (1) CA2669069C (OSRAM)
DK (2) DK2489662T3 (OSRAM)
ES (2) ES2523401T3 (OSRAM)
IL (1) IL198847A (OSRAM)
MX (1) MX2009005048A (OSRAM)
TW (1) TWI460166B (OSRAM)
WO (1) WO2008062376A2 (OSRAM)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
DK1689726T3 (da) 2003-11-21 2010-12-06 Actelion Pharmaceuticals Ltd 5-(benz-(z)-yliden)-thiazolidin-4-on-derivater som immunsuppresserende midler
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
DK2278960T4 (da) 2008-03-17 2020-01-27 Actelion Pharmaceuticals Ltd Dosisregimen til en selektiv sip1 receptoragonist
GB0819182D0 (en) 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms
SMT202000298T1 (it) 2012-08-17 2020-07-08 Actelion Pharmaceuticals Ltd Processo per la produzione di (2z,5z)-5-(3-cloro-4((r)-2,3-diidrossipropossi) benziliden)-2-(propilimmino)-3-(o-tolil)tiazolidin-4-one e intermedio usato in detto processo
MA41139A (fr) 2014-12-11 2017-10-17 Actelion Pharmaceuticals Ltd Combinaison pharmaceutique comportant un agoniste sélectif du récepteur sip1
PL3256125T3 (pl) 2014-12-11 2022-05-09 Actelion Pharmaceuticals Ltd Schemat dawkowania ponesimodu, selektywnego agonisty receptora s1p1
JOP20190207A1 (ar) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على بونيسيمود
US11220488B2 (en) 2017-09-19 2022-01-11 Teva Pharmaceuticals International Gmbh Crystalline polymorph of Ponesimod
US11014897B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof
US11186556B1 (en) 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
US11014940B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Thiazolidinone and oxazolidinone compounds and formulations
US11013723B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms of a thiazolidinone compound, compositions and methods of use thereof
KR20220034818A (ko) * 2019-07-10 2022-03-18 바이엘 악티엔게젤샤프트 2-(페닐이미노)-1,3-티아졸리딘-4-온의 제조 방법
WO2021005082A1 (de) * 2019-07-10 2021-01-14 Bayer Aktiengesellschaft Verfahren zur herstellung von 2-(phenylimino)-1,3-thiazolidin-4-onen
WO2021084068A1 (en) 2019-10-31 2021-05-06 Idorsia Pharmaceuticals Ltd Combination of a cxcr7 antagonist with an s1p1 receptor modulator
KR20200019639A (ko) 2020-01-30 2020-02-24 전대연 만남의 스마트 도착시스템
EP4107149A1 (de) * 2020-02-18 2022-12-28 Bayer Aktiengesellschaft Verfahren zur herstellung von 2-(phenylimino)-3-alkyl-1,3-thiazolidin-4-onen
WO2023022896A1 (en) 2021-08-17 2023-02-23 Teva Czech Industries S.R.O Polymorphs of ponesimod
EP4212156A1 (en) 2022-01-13 2023-07-19 Abivax Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator
WO2023152691A1 (en) * 2022-02-10 2023-08-17 Metrochem Api Pvt Ltd Process for the preparation of ponesimod and its intermediates thereof
CN117924210A (zh) * 2024-01-22 2024-04-26 赣南师范大学 一种2-亚氨基噻唑烷-4-酮类化合物的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3077402A (en) * 1954-12-06 1963-02-12 Polaroid Corp Photographic color processes, products, and compositions
NL270002A (OSRAM) 1960-10-08
OA03835A (fr) * 1970-07-17 1971-12-24 Rhone Poulenc Sa Nouveaux dérivés de la thiazolidine, leur préparation et les compositions qui les contiennent.
DE69123738T2 (de) 1990-04-27 1997-07-03 Orion-Yhtymae Oy, Espoo Pharmakologisch aktive catecholderivate
TW221689B (OSRAM) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
ATE212018T1 (de) * 1993-02-26 2002-02-15 Otsuka Pharma Co Ltd Thiazole oder imidazole derivate als maillard reaktion inhibitoren
KR960022486A (ko) 1994-12-29 1996-07-18 김준웅 신규 티아졸리딘-4-온 유도체
US6353006B1 (en) * 1999-01-14 2002-03-05 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
ATE393150T1 (de) 1999-09-14 2008-05-15 Shionogi & Co 2-imino-1,3-thiazin-derivate
CA2355243C (en) * 1999-11-12 2009-01-27 Fujimoto Brothers Co., Ltd. Novel 2-(n-cyanoimino)thiazolidin-4-one derivatives
US20050019825A9 (en) * 2002-03-15 2005-01-27 Qing Dong Common ligand mimics: pseudothiohydantoins
CA2493843C (en) 2002-07-10 2012-04-17 Applied Research Systems Ars Holding N.V. Azolidinone-vinyl fused-benzene derivatives
GB0217152D0 (en) 2002-07-24 2002-09-04 Novartis Ag Organic compounds
NZ539873A (en) * 2002-11-22 2008-09-26 Smithkline Beecham Corp Novel chemical compounds, thiazolidin-4-one, thiazol-4-one
US20040167192A1 (en) * 2003-01-16 2004-08-26 David Solow-Cordero Methods of treating conditions associated with an Edg-7 receptor
DK1689726T3 (da) * 2003-11-21 2010-12-06 Actelion Pharmaceuticals Ltd 5-(benz-(z)-yliden)-thiazolidin-4-on-derivater som immunsuppresserende midler
EP1718642A4 (en) * 2004-02-25 2010-11-24 Glaxosmithkline Llc NEW CHEMICAL COMPOUNDS
WO2006094233A1 (en) * 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. N,n'-dicyclic isothiourea sirtuin modulators
DK2278960T4 (da) * 2008-03-17 2020-01-27 Actelion Pharmaceuticals Ltd Dosisregimen til en selektiv sip1 receptoragonist
GB0819182D0 (en) * 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms

Also Published As

Publication number Publication date
KR20090081009A (ko) 2009-07-27
BRPI0718986A2 (pt) 2014-02-11
US20110201821A2 (en) 2011-08-18
EP2094676B1 (en) 2013-04-10
IL198847A (en) 2015-07-30
WO2008062376A2 (en) 2008-05-29
AU2007323042A1 (en) 2008-05-29
CN103087004A (zh) 2013-05-08
CA2669069C (en) 2015-02-17
TWI460166B (zh) 2014-11-11
CN101541772B (zh) 2013-04-17
US8263780B2 (en) 2012-09-11
EP2094676A2 (en) 2009-09-02
EP2489662B1 (en) 2014-08-06
JP4669564B2 (ja) 2011-04-13
US20100317867A1 (en) 2010-12-16
TW200831474A (en) 2008-08-01
ES2410793T3 (es) 2013-07-03
IL198847A0 (en) 2010-02-17
MX2009005048A (es) 2009-05-25
CN101541772A (zh) 2009-09-23
WO2008062376A3 (en) 2008-07-10
DK2094676T3 (da) 2013-06-10
KR101255879B1 (ko) 2013-04-17
CA2669069A1 (en) 2008-05-29
JP2010510976A (ja) 2010-04-08
DK2489662T3 (da) 2014-10-20
EP2489662A1 (en) 2012-08-22
AU2007323042B2 (en) 2012-12-20

Similar Documents

Publication Publication Date Title
ES2523401T3 (es) Intermedios de un nuevo procedimiento para la preparación de derivados de 5-benciliden-2-alquilimino-3- feniltiazolidin-4-ona
US8912340B2 (en) Process for the preparation of 2-imino-thiazolidin-4-one derivatives
ES2352555T3 (es) Derivados de 5-(benc-(z)-iliden)tiazolidin-4-ona como agentes inmunosupresores.
JPH04234864A (ja) ２−クロロチアゾール類の製造方法
WO1992005165A1 (en) Diphenylpiperazine derivative and drug for circulatory organ containing the same
JP2018527324A (ja) ガンを処置するのに使用するための置換疎水性ベンゼンスルホンアミドチアゾール化合物
LV10437B (en) Substituted 1-(1h-imidazole-4-yl)alkylbenzamides
JPS6018653B2 (ja) 新規な２，６−ジ置換２−フエニルイミノ−イミダゾリジンおよびその酸付加塩の製造方法
CN110483417B (zh) 一种DACOs类NNRTIs氨基酸酯衍生物、其制备方法、药物组合物及应用
CN101456862B (zh) 含有吡唑并嘧啶酮的苯基胍衍生物、其药物组合物及其制备方法和用途
EP3192792B1 (en) Aminosulfonyl-based compounds, preparation method therefor and use thereof
HU210683B (en) Process for producing n-benzyl-n1-(phenyl-alkyl)-thiourea derivatives and pharmaceutical compositions containing the same
JP2006500409A5 (OSRAM)
IE58684B1 (en) Aminobenzamide derivatives
LT3211B (en) Novel derivatives of hydroxyanthranilic acid, methods for their preparation and the use thereof
ES2443538B1 (es) Compuestos beta-lactámicos inhibidores de APAF1
MXPA06005590A (en) 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
BRPI0718986B1 (pt) Processo para a preparação de um composto
KR20010102365A (ko) 폴리사이클릭 티아졸-2-일리드 아민, 이의 제조방법 및약제로서의 이의 용도